Franklin Lakes-based medical technology company BD (Becton, Dickinson and Co.), unveiled a new software application designed to help hospitals and health systems identify drug diversion at the 2018 American Society of Health-System Pharmacists Midyear Meeting this week in Anaheim, Calif.
In a press release, BD said that as part of the BD HealthSight platform that is designed to support enterprise-wide medication management, the new BD HealthSight diversion management application is “the next step in the company’s efforts to address drug diversion through integrated solutions and analytics.”
The solution leverages data from existing BD products to provide actionable insights to assist with a hospital or health system’s diversion investigations.
“Medication diversion is a growing and complex challenge for hospitals and health systems. We believe that to best address this challenge, a holistic approach to medication management that includes a combination of connected technologies and robust analytics is required,” Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD, said in a statement.
BD HealthSight diversion management is a hosted, cloud-based application that assists with drug-diversion investigations by creating an investigation workflow to monitor, triage and assign potential diversion cases to specific investigators.